Zafon Elisenda, Echevarría Igor, Barrabés Sílvia, Manzano Blanca R, Jalón Félix A, Rodríguez Ana M, Massaguer Anna, Espino Gustavo
Universitat de Girona, Departament de Biologia, Facultat de Ciències, Maria Aurelia Capmany 40, 17003 Girona, Spain.
Universidad de Burgos, Departamento de Química, Facultad de Ciencias, Plaza Misael Bañuelos s/n, 09001, Burgos, Spain.
Dalton Trans. 2021 Dec 20;51(1):111-128. doi: 10.1039/d1dt03080a.
Photodynamic therapy is an alternative to classical chemotherapy due to its potential to reduce side effects by a controlled activation of a photosensitizer through local irradiation with light. The photosensitizer then interacts with oxygen and generates reactive oxygen species. Iridium biscyclometallated complexes are very promising photosensitizers due to their exceptional photophysical properties and their ability to target mitochondria. Four Ir(III) biscyclometallated complexes of formula [Ir(C^N)(N^N')]Cl, where N^N' is a ligand containing a benzimidazolyl fragment, have been synthesized and characterized. The C^N ligands were 2-phenylpyridinate (ppy) and 2-(2,4-difluorophenyl)pyridinate (dfppy). The complexes exhibited high photostability. The electrochemical and photophysical properties were modulated by both the cyclometallating and the ancillary ligands. The dfppy derivatives yielded the highest emission energy values, quantum yields of phosphorescence and excited state lifetimes. All complexes generated O in aerated solutions upon irradiation. Biological studies revealed that these complexes have a moderate cytotoxicity in the dark against different human cancer cell lines: prostate (PC-3), colon (CACO-2) and melanoma (SK-MEL-28), and against non-malignant fibroblasts (CCD-18Co). However, derivatives with ppy ligands ([1a]Cl, [2a]Cl) yielded a relevant photodynamic activity upon light irradiation (450 nm, 24.1 J cm), with phototoxicity indexes (EC/EC) of 20.8 and 17.3, respectively, achieved in PC-3 cells. Mechanistic studies showed that these complexes are taken up by the cells through endocytosis and preferentially accumulate in mitochondria. Upon photoactivation, the complexes induced mitochondrial membrane depolarization and DNA damage, thus triggering cell death, mainly by apoptosis. Complex [1a]Cl is also able to oxidize NADH. This mitochondria-targeted photodynamic mechanism greatly inhibited the reproductive capacity of cancer cells and provides a valuable alternative to traditional chemotherapy for the controlled treatment of cancer.
光动力疗法是传统化疗的一种替代方法,因为它有可能通过用光进行局部照射来控制激活光敏剂,从而减少副作用。然后,光敏剂与氧相互作用并产生活性氧。铱双环金属化配合物因其优异的光物理性质和靶向线粒体的能力而成为非常有前景的光敏剂。已经合成并表征了四种通式为[Ir(C^N)(N^N')]Cl的Ir(III)双环金属化配合物,其中N^N'是含有苯并咪唑基片段的配体。C^N配体为2-苯基吡啶(ppy)和2-(2,4-二氟苯基)吡啶(dfppy)。这些配合物表现出高光稳定性。电化学和光物理性质受到环金属化配体和辅助配体的调节。dfppy衍生物产生最高的发射能量值、磷光量子产率和激发态寿命。所有配合物在曝气溶液中照射时都会产生单线态氧。生物学研究表明,这些配合物在黑暗中对不同的人类癌细胞系:前列腺癌(PC-3)、结肠癌(CACO-2)和黑色素瘤(SK-MEL-28)以及非恶性成纤维细胞(CCD-18Co)具有中等细胞毒性。然而,含有ppy配体的衍生物([1a]Cl、[2a]Cl)在光照射(450 nm,24.1 J/cm²)时产生了显著的光动力活性,在PC-3细胞中实现的光毒性指数(EC₅₀/EC₁₀)分别为20.8和17.3。机理研究表明,这些配合物通过内吞作用被细胞摄取,并优先在线粒体中积累。光激活后,这些配合物诱导线粒体膜去极化和DNA损伤,从而主要通过凋亡触发细胞死亡。配合物[1a]Cl还能够氧化NADH。这种靶向线粒体的光动力机制极大地抑制了癌细胞的繁殖能力,并为癌症的可控治疗提供了一种有价值的传统化疗替代方法。